Catalyst Wire Dossier Catalyst Wire Dossier

APTIOM

Eslicarbazepine acetate · Sumitomo Pharma America, Inc.
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for APTIOM, covering 2013-11-08 to 2024-06-20. Get the full timeline:

Most recent: FDA Approved: APTIOM — Supplemental Application (Sumitomo Pharma America, Inc.)

See pricing